BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34239732)

  • 1. Implications of Regionalizing Care in the Developing World: Impact of Distance to Referral Center on Compliance to Biopsy Recommendations in a Brazilian Prostate Cancer Screening Cohort.
    Freedland AR; Muller RL; Hoyo C; Turner EL; Moorman PG; Faria EF; Carvalhal GF; Reis RB; Mauad EC; Carvalho AL; Freedland SJ
    Prostate Cancer; 2021; 2021():6614838. PubMed ID: 34239732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family history of prostate cancer and prostate tumor aggressiveness in black and non-black men;results from an equal access biopsy study.
    Jenkins KR; Oyekunle T; Howard LE; Wiggins EK; Freedland SJ; Allott EH
    Cancer Causes Control; 2021 Apr; 32(4):337-346. PubMed ID: 33532986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort.
    Gaines AR; Turner EL; Moorman PG; Freedland SJ; Keto CJ; McPhail ME; Grant DJ; Vidal AC; Hoyo C
    Cancer Causes Control; 2014 Aug; 25(8):1029-35. PubMed ID: 24879044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between exercise and BMI; results from an equal access, racially diverse biopsy study.
    Michael J; Oyekunle T; Howard L; De Hoedt A; Hoyo C; Grant D; Freedland S
    Cancer Causes Control; 2019 Jan; 30(1):13-20. PubMed ID: 30523509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Outcomes for Men in a Prostate Screening Trial with an Initial Benign Prostate Biopsy: A Population-based Cohort.
    Palmstedt E; Månsson M; Frånlund M; Stranne J; Pihl CG; Hugosson J; Arnsrud Godtman R
    Eur Urol Oncol; 2019 Nov; 2(6):716-722. PubMed ID: 31411967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between literacy, compliance with prostate cancer screening, and cancer aggressiveness: results from a Brazilian screening study.
    Tobias-Machado M; Carvalhal GF; Freitas CH; Reis RB; Reis LO; Nogueira L; Machado RD; Magnabosco W; Vieira RA; Mauad EC; Carvalho AL; Faria EF;
    Int Braz J Urol; 2013; 39(3):328-34. PubMed ID: 23849582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between family history of prostate cancer and positive biopsies in a Brazilian screening program.
    Muller RL; Faria EF; Carvalhal GF; Reis RB; Mauad EC; Carvalho AL; Freedland SJ
    World J Urol; 2013 Oct; 31(5):1273-8. PubMed ID: 22820620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association Between Age, Prostate Cancer Risk, and Higher Gleason Score in a Long-term Screening Program: Results from the Göteborg-1 Prostate Cancer Screening Trial.
    Godtman RA; Kollberg KS; Pihl CG; Månsson M; Hugosson J
    Eur Urol; 2022 Sep; 82(3):311-317. PubMed ID: 35120773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study.
    Freedland SJ; Hamilton RJ; Gerber L; Banez LL; Moreira DM; Andriole GL; Rittmaster RS
    Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):254-9. PubMed ID: 23567655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Finnish prostate cancer screening trial: analyses on the screening failures.
    Kilpeläinen TP; Tammela TL; Malila N; Hakama M; Santti H; Määttänen L; Stenman UH; Kujala P; Auvinen A
    Int J Cancer; 2015 May; 136(10):2437-43. PubMed ID: 25359457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive predictive value for presumptive diagnoses of skin cancer and compliance with follow-up among patients attending a community screening program.
    Jonna BP; Delfino RJ; Newman WG; Tope WD
    Prev Med; 1998; 27(4):611-6. PubMed ID: 9672956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging evidence for Gleason grade migration and distance impact in prostate cancer? An analysis of the rapid access prostate clinic in a tertiary referral center: St. Vincent's University Hospital, Dublin (2009-2011).
    O'Kelly F; Thomas AZ; Murray D; Lee P; O'Carroll RF; Nicholson P; Forristal H; Swan N; Galvin D; Mulvin D; Quinlan DM
    Ir J Med Sci; 2013 Sep; 182(3):487-91. PubMed ID: 23417241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer risk assessment in men with an initial P.S.A. below 3 ng/mL: results from the Göteborg randomized population-based prostate cancer screening trial.
    Frånlund M; Arnsrud Godtman R; Carlsson SV; Lilja H; Månsson M; Stranne J; Hugosson J
    Scand J Urol; 2018 Aug; 52(4):256-262. PubMed ID: 30241447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Men under the age of 55 years with screen detected prostate cancer do not have less significant disease compared to older men in a population of patients in Australia.
    Dantanarayana ND; Hossack T; Cozzi P; Brooks A; Lau H; Delprado W; Patel MI
    BMC Urol; 2015 Dec; 15():124. PubMed ID: 26715039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline subject characteristics predictive of compliance with study-mandated prostate biopsy in men at risk of prostate cancer: results from REDUCE.
    Fischer S; Sun S; Howard LE; Moreira DM; Castro-Santamaria R; Andriole GL; Vidal AC; Freedland SJ
    Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):202-8. PubMed ID: 26926927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer: The Prospective PROMM-AS Study.
    Valentin B; Arsov C; Ullrich T; Al-Monajjed R; Boschheidgen M; Hadaschik BA; Giganti F; Giessing M; Lopez-Cotarelo C; Esposito I; Antoch G; Albers P; Radtke JP; Schimmöller L
    Eur Urol Open Sci; 2024 Jan; 59():30-38. PubMed ID: 38298772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital rectal examination and the diagnosis of prostate cancer--a study based on 8 years and three screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.
    Gosselaar C; Roobol MJ; van den Bergh RC; Wolters T; Schröder FH
    Eur Urol; 2009 Jan; 55(1):139-46. PubMed ID: 18406045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer.
    Hegde JV; Chen MH; Mulkern RV; Fennessy FM; D'Amico AV; Tempany CM
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):e101-7. PubMed ID: 23040223
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.